A snapshot of what we do

We advise listed and private companies, private equity funds, entrepreneurs, and start-ups on buying, selling and investing in businesses, raising capital in the public and private markets and on their important commercial transactions.

We provide strategic, corporate governance and compliance advice to boards of directors, senior executives and corporates.

We advise on general corporate and commercial matters.

We are a specialist corporate law firm based in Auckland, New Zealand.

Our directors, David Flacks and Daniel Wong, together have many years' top‑tier domestic and international experience across all areas of corporate and commercial law including:

  • Buying, selling and investing in businesses, including Takeovers Code transactions
  • Capital raisings, including equity crowdfunding, IPOs and start-up funding
  • Strategic, corporate governance and compliance advice
  • Resolving board, and shareholder, disputes and ownership issues
  • Joint ventures, shareholders’ arrangements and other commercial transactions
  • General corporate and commercial law advice

Although we specialise in corporate law, we regularly access other areas of expertise as required to provide the full range of legal services. We take responsibility for project managing those other experts so that you have a single point of contact

As well as our corporate law expertise:

  • We are admired for our "attentiveness and business-orientation", and described as "very commercial in [our] approach" (Chambers Asia-Pacific 2019
  • We are described by clients as "very diligent and responsive with top-notch business acumen" and "equally adept across all sizes of transaction" (The Legal 500 Asia Pacific 2019)
  • We are highly respected for our long-standing track record in completing M&A, and capital markets, transactions
  • We have a reputation for providing clear, and concise, solutions-focused advice
  • We have deep relationships with New Zealand capital markets regulators and participants
  • We offer access to senior, experienced lawyers only

Our expertise is independently recognised:

  • Winner of "Boutique Law Firm of the Year" at the New Zealand Law Awards 2019
  • Finalist for "M&A Deal of the Year", "Capital Markets Deal of the Year" and "Consumer, Media and Tech Deal of the Year" at the New Zealand Law Awards 2019
  • Finalist for "Boutique Law Firm of the Year" and "Deal Team of the Year (<100 Lawyers)" at each of the last three New Zealand Law Awards (2019, 2018 and 2017)
  • Leading firm for Corporate/Commercial in Chambers Asia-Pacific 2020
  • David Flacks and Daniel Wong are each individually ranked for Corporate/Commercial in Chambers Asia-Pacific 2020
  • Leading firm for Corporate and M&A in The Legal 500 Asia Pacific 2019
  • Daniel Wong is in the elite tier of leading individuals for Corporate and M&A in The Legal 500 Asia Pacific 2019
  • Winner of "Mid-Market Deal of the Year" at the New Zealand Law Awards 2016
AP leading firm

David Flacks

Director

p. +64 9 377 8883
m. +64 21 687 844

David is a highly-respected, leading New Zealand corporate lawyer. He has a reputation for providing clear, concise advice, and for achieving pragmatic, commercial outcomes.
David is a highly-respected, leading New Zealand corporate lawyer. He has a reputation for providing clear, concise advice, and for achieving pragmatic, commercial outcomes.

David is a highly-respected, leading New Zealand corporate lawyer.  He has a reputation for providing clear, concise advice, and for achieving pragmatic, commercial outcomes.

David was a partner at Bell Gully for many years, except for four years in the 1990s when he was a member of the senior executive team, general counsel and company secretary of Carter Holt Harvey.

Clients have commented (through Chambers Asia-Pacific, a respected global legal directory) that David “uses his broad international and in‑house experience to bring a pragmatic, commercial perspective to his work” and “is affable and easy to deal with, but not a pushover”.  The 2015 edition refers to David’s “unflappable nature,” and notes that “when you've got emotional shareholders and a process is very convoluted, he can just walk through the middle of it; he reads people and tone brilliantly”.

David is a recent former member of the Takeovers Panel and recent Chair of the NZ Markets Disciplinary Tribunal.

Qualifications

BA (Cantab), MA (Cantab), St John’s College, Cambridge University

Admitted

1979, England and Wales (non-practising)
1985, New Zealand

Current governance roles

Director of Vero Insurance New Zealand
Director of Vero Liability Insurance
Director of Asteron Life
Chair of Harmoney Corp
Chair of AFT Pharmaceuticals
Deputy Chair of the New Zealand Venture Investment Fund
Chair of Upside Biotechnologies
Chair of NZX’s Regulatory Governance Committee

David is a highly-respected, leading New Zealand corporate lawyer.  He has a reputation for providing clear, concise advice, and for achieving pragmatic, commercial outcomes.

David was a partner at Bell Gully for many years, except for four years in the 1990s when he was a member of the senior executive team, general counsel and company secretary of Carter Holt Harvey.

Clients have commented (through Chambers Asia-Pacific, a respected global legal directory) that David “uses his broad international and in‑house experience to bring a pragmatic, commercial perspective to his work” and “is affable and easy to deal with, but not a pushover”.  The 2015 edition refers to David’s “unflappable nature,” and notes that “when you've got emotional shareholders and a process is very convoluted, he can just walk through the middle of it; he reads people and tone brilliantly”.

David is a recent former member of the Takeovers Panel and recent Chair of the NZ Markets Disciplinary Tribunal.

Qualifications

BA (Cantab), MA (Cantab), St John’s College, Cambridge University

Admitted

1979, England and Wales (non-practising)
1985, New Zealand

Current governance roles

Director of Vero Insurance New Zealand
Director of Vero Liability Insurance
Director of Asteron Life
Chair of Harmoney Corp
Chair of AFT Pharmaceuticals
Deputy Chair of the New Zealand Venture Investment Fund
Chair of Upside Biotechnologies
Chair of NZX’s Regulatory Governance Committee

Daniel Wong

Director

p. +64 9 377 8881
m. +64 21 285 1088

Daniel advises on a broad spectrum of corporate and capital markets transactions. His success on mid-market M&A transactions has been recognised through nominations as finalist for “Mid-Market Deal of the Year” at both the 2017 and 2016 New Zealand Law Awards.
Daniel advises on a broad spectrum of corporate and capital markets transactions. His success on mid-market M&A transactions has been recognised through nominations as finalist for “Mid-Market Deal of the Year” at both the 2017 and 2016 New Zealand Law Awards.

Daniel advises on a broad spectrum of corporate and capital markets transactions.  His success on mid-market M&A transactions has been recognised through nominations as finalist for “Mid-Market Deal of the Year” at both the 2017 and 2016 New Zealand Law Awards.

Daniel has market-leading expertise on innovative forms of capital raising, having advised the issuers of New Zealand’s first and second (and only) offers of social bonds, as well as regularly advising companies on their equity crowdfunding campaigns.

Daniel is in the elite tier of leading individuals for Corporate and M&A in The Legal 500 Asia Pacific 2019, and a previous edition describes him as "exemplary, client-driven and commercially-focused".  

Daniel is praised for being "hugely commercial" and a "thoughtful and strategic adviser" in Chambers Asia-Pacific, which also recognises his expertise in joint ventures, strategic investments, capital raising and M&A transactions.

Before co-founding Flacks & Wong, Daniel was a senior associate at Bell Gully in Auckland and Freshfields Bruckhaus Deringer LLP in London.

Daniel draws on his corporate law expertise in regularly presenting practical, transaction‑based company law workshops to junior and intermediate lawyers.  

Qualifications

LLB (First Class Honours), BCA (Finance and Management), Victoria University of Wellington

Admitted

2002, New Zealand
2008, England and Wales (non-practising)

Current governance roles

Director of the NZ Shareholders Association Inc.
Trustee of the New Zealand Symphony Orchestra Foundation
Director of the New Zealand Symphony Orchestra

Daniel advises on a broad spectrum of corporate and capital markets transactions.  His success on mid-market M&A transactions has been recognised through nominations as finalist for “Mid-Market Deal of the Year” at both the 2017 and 2016 New Zealand Law Awards.

Daniel has market-leading expertise on innovative forms of capital raising, having advised the issuers of New Zealand’s first and second (and only) offers of social bonds, as well as regularly advising companies on their equity crowdfunding campaigns.

Daniel is in the elite tier of leading individuals for Corporate and M&A in The Legal 500 Asia Pacific 2019, and a previous edition describes him as "exemplary, client-driven and commercially-focused".  

Daniel is praised for being "hugely commercial" and a "thoughtful and strategic adviser" in Chambers Asia-Pacific, which also recognises his expertise in joint ventures, strategic investments, capital raising and M&A transactions.

Before co-founding Flacks & Wong, Daniel was a senior associate at Bell Gully in Auckland and Freshfields Bruckhaus Deringer LLP in London.

Daniel draws on his corporate law expertise in regularly presenting practical, transaction‑based company law workshops to junior and intermediate lawyers.  

Qualifications

LLB (First Class Honours), BCA (Finance and Management), Victoria University of Wellington

Admitted

2002, New Zealand
2008, England and Wales (non-practising)

Current governance roles

Director of the NZ Shareholders Association Inc.
Trustee of the New Zealand Symphony Orchestra Foundation
Director of the New Zealand Symphony Orchestra

Katie Green

Senior Associate

p. +64 9 377 8884
m. +64 21 285 1052

Katie is an experienced corporate and commercial lawyer, having advised on a range of M&A, private equity and capital markets transactions as well as corporate governance matters.
Katie is an experienced corporate and commercial lawyer, having advised on a range of M&A, private equity and capital markets transactions as well as corporate governance matters.

Katie is an experienced corporate and commercial lawyer, having advised on a range of M&A, private equity and capital markets transactions as well as corporate governance matters.

Katie regularly advises on consumer and privacy law matters, sponsorship, franchising and other complex commercial arrangements. 

Before joining Flacks & Wong, Katie was a senior associate at Herbert Smith Freehills in London and a solicitor at Bell Gully in Auckland.  Katie has also undertaken secondments at Carter Holt Harvey, assisting its business units with a range of commercial agreements and transactions.

 

 

Qualifications

LLB, BCom, University of Auckland

Admitted

2011, New Zealand

 

 

 
 
 
 
 
 
 
 
 

Katie is an experienced corporate and commercial lawyer, having advised on a range of M&A, private equity and capital markets transactions as well as corporate governance matters.

Katie regularly advises on consumer and privacy law matters, sponsorship, franchising and other complex commercial arrangements. 

Before joining Flacks & Wong, Katie was a senior associate at Herbert Smith Freehills in London and a solicitor at Bell Gully in Auckland.  Katie has also undertaken secondments at Carter Holt Harvey, assisting its business units with a range of commercial agreements and transactions.

 

 

Qualifications

LLB, BCom, University of Auckland

Admitted

2011, New Zealand

 

 

 
 
 
 
 
 
 
 
 

The directors of Flacks & Wong have advised:

  • Tanarra Capital on its investment in New Zealand Wool Scouring
  • Ninety Four Feet on its partnership with Augusta Capital to develop the Lakeview site in Queenstown
  • xTV Networks on its acquisition, and the reverse listing on the ASX, of New Zealand Coastal Seafoods, and its contemporaneous IPO in New Zealand and Australia
  • the management team of ACG Schools on the sale of ACG Schools by Pacific Equity Partners to Inspired Education
  • SeaDragon on a convertible loan note facility provided by the Masthead group
  • Coretex on the subscription by Movac of equity into Coretex
  • the Special Division of NZ Markets Disciplinary Tribunal on the reverse NZX listing of PaySauce
  • Serko on its US share-for-share acquisition of InterplX
  • Impact Enterprise Fund on its investments in Waikaitu and Melon Health
  • Pioneer Capital, as a substantial shareholder of Orion Health, on the Hg Capital transaction
  • Milford Asset Management, as a substantial shareholder of SLI Systems, on the ESW takeover offer
  • Archipro, Chapter 2 Sports, the Dust Palace and Zeffer Cider on their respective equity crowdfunding campaigns
  • Appliance Shed on the sale of its business to Noel Leeming
  • Keytone Dairy Corporation on its acquisition of Keytone Enterprises (NZ) Company, and its contemporaneous listing on the ASX, and IPO in New Zealand and Australia
  • Oyster Property Group on its joint venture with KKR to acquire the Central Park Corporate Centre
  • Serko on the establishment of its non-executive director fixed trading share plan
  • Genesis Youth Trust on its (and New Zealand's second) offer of social bonds
  • APM Workcare on its (and New Zealand's first) offer of social bonds
  • The vendors on the sale of Compac Sorting Equipment to Tomra Systems
  • Coretex on its acquisition (by way of merger) of Imarda and International Telematics, and the subsequent subscription by Milford of equity into Coretex
  • Teva Pharmaceuticals on the application of New Zealand's overseas investment regime to its acquisition of Mylan
  • Orion Health on its IPO in New Zealand and Australia and its listing on the NZX Main Board and the ASX
  • The Better Bar Group of companies on the sale of their business to Veritas Investments
  • The Commonwealth of Australia on its IPO of Medibank Private in New Zealand
  • The principal vendors on the sale of Interpac Packaging to Huhtamaki
  • Serko on its IPO in New Zealand and Australia and its listing on the NZX Main Board
  • Rex Bionics on its reverse listing on the AIM market
  • Bauer Media Group on its acquisition of certain magazine titles from NZME.
  • AIM-listed Endace on its public takeover offer by Emulex Corporation

Contact us

Feel free to give one of us a call and let’s chat over a coffee. We don’t charge for an initial discussion and we’ll be upfront on what we think the issues are and whether we can assist.

Contact details for our lawyers appear on the ‘Our team’ section above. Alternatively, please contact us by completing this form.

Level 5, Shortland Chambers Building
70 Shortland Street
PO Box 591
Auckland 1140
New Zealand

Please correct the following error(s):

  • {{ error.value }}